Related Experiment Video
Updated: Jul 17, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
[Pulmonary involvement in polymyositis and dermatomyositis]
I Tillie-Leblond1, G Colin, J Lelong
1Service de Pneumologie et d'Immuno-Allergologie, Hôpital Calmette, Lille, France. i-tillie@chru-lille.fr
Polymyositis and dermatomyositis can cause respiratory issues like diffuse interstitial pneumonitis (DIP), a serious complication. Early detection and treatment of these inflammatory muscle diseases are crucial for patient outcomes.
Area of Science:
- Rheumatology and Pulmonology
- Autoimmune myopathies
- Interstitial lung disease
Context:
- Polymyositis and dermatomyositis are inflammatory myopathies affecting skeletal muscle.
- Respiratory involvement, including diffuse interstitial pneumonitis (DIP), is a significant complication.
- DIP in polymyositis is associated with poor prognosis and is a leading cause of mortality.
Purpose:
- To outline the respiratory manifestations of polymyositis and dermatomyositis.
- To highlight the prognostic significance of diffuse interstitial pneumonitis (DIP).
- To discuss the diagnostic markers, such as anti-synthetase antibodies, and treatment approaches.
Summary:
- Inflammatory myopathies can lead to respiratory complications, including inhalation pneumonia and respiratory failure.
- Diffuse interstitial pneumonitis (DIP) is a severe manifestation, often with acute onset (30-47% of cases).
- Anti-synthetase antibodies, particularly anti-JO-1, are present in approximately 75% of cases. Treatment involves immunosuppressants and corticosteroids.
Impact:
- Understanding respiratory involvement is critical for managing polymyositis and dermatomyositis.
- Identifying DIP early can guide prognosis and treatment strategies.
- This knowledge aids in improving patient morbidity and mortality rates associated with these conditions.
Related Concept Videos
Myocarditis I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests